Cancer Biology
A section of Biology (ISSN 2079-7737).
Section Information
The Cancer Biology Section aims to advance our understanding of cancer as a complex and dynamic disease in which cancer cells interact and co-evolve with the tumor microenvironment and host physiology, in either the untreated state or in response to therapeutic pressures.
While normal cells follow strictly regulated processes of growth, division, and death, these controls fail in cancer. Our understanding of the (patho)biology of cancer has evolved over time. The transformation of a normal cell into a cancer cell occurs in several steps, including the maintenance of proliferative signaling, the evasion of growth suppressors, resistance to cell death, the facilitation of replicative immortality, the induction of angiogenesis, and the activation of invasion and metastasis. These changes often take place due to genetic mutations. In addition, recent advances have shed light on the role of the tumor microenvironment, interactions with the immune system, and epigenetic changes.
We welcome submissions of original research, reviews, technical and methodological advances, and brief communications in all areas of cancer research. Particular emphasis is placed on studies of tumor heterogeneity and evolution, the tumor microenvironment, immune evasion and rejuvenation, metabolic fitness and reprogramming, metastasis, preclinical modeling, biomarker discovery, and early detection.
The overall aim of this section is to support the publication of research that advances the field of cancer biology. Understanding cancer at the biological level is key to developing better diagnostic tools, treatments, and, ultimately, cures.
Subject Areas
- Cancer progression and metastasis;
- Tumor microenvironment;
- Cancer cell migration;
- Tumor angiogenesis and vascular mimicry;
- Targeted therapy and resistance;
- Cancer immunology;
- Single-cell omics;
- Cancer metabolism;
- Cancer evolution;
- Tumor biomechanics;
- Tumor biomarkers;
- Oncogenetics.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- DNA Repair and DNA Damage Response (DDR) in Oncology (Deadline: 31 October 2025)
- Breast Cancer: Molecular and Cellular Mechanism and Biomarkers (Deadline: 30 November 2025)
- Unraveling the Tumor-Immune Microenvironment Using Transcriptomics (Deadline: 30 November 2025)
- Immune Microenvironment and Molecular Mechanism of Glioma (Deadline: 31 December 2025)
- Recent Advances in Tumor Microenvironment Biology (Deadline: 31 December 2025)
- Protein Kinases: Key Players in Carcinogenesis (Deadline: 31 December 2025)
- Molecular Mechanisms of Bone Metastasis in Cancer (Deadline: 15 January 2026)
- Tumor Biomechanics and Mechanobiology (Deadline: 31 January 2026)
- Molecular Insights into the Immune Contexture of Tumors (Deadline: 31 March 2026)
- Recent Advances in Biological Research on Prostate Cancer (Deadline: 31 May 2026)
- New Insights in Cancer Genetics—2nd Edition (Deadline: 31 May 2026)
- Head and Neck Cancer: Current Advances and Future Perspectives (Deadline: 31 May 2026)
- Advances in Biological Breast Cancer Research (2nd Edition) (Deadline: 30 June 2026)
- Signalling Pathways in Cancer and Disease (Deadline: 30 September 2026)